healthybankers

March 27, 2026

Low Dose Naltrexone TRPM3 Long COVID: The Ion Channel Breakthrough Rewriting Immunology

A landmark 2025 Griffith University study reveals that low dose naltrexone TRPM3 long COVID research has delivered the most mechanistically specific finding yet: LDN restores the faulty ion channel that keeps Long COVID patients bioenergetically stuck.
March 22, 2026

Nattokinase for Long COVID Recovery: The Fibrinolytic Enzyme Dissolving Microclots & Spike Protein Fragments

Nattokinase for Long COVID is emerging as one of the most mechanistically coherent post-viral recovery interventions. Backed by the Tanikawa et al. 2022 spike protein degradation study and Pretorius microclot research, this deep-dive explains the bioenergetic failure cascade and presents a stacked protocol for finance professionals.
March 17, 2026

Mitochondrial Health for Professionals: NAD+, Energy & Longevity

Mitochondrial health for professionals is now front-page science — and it directly impacts your energy, focus, and career longevity. Learn how chronic stress damages your mitochondria, and what NAD+, NMN, Urolithin A, and lifestyle interventions can do to reverse it.